Address
:
[go:
up one dir
,
main page
]
Include Form
Remove Scripts
Accept Cookies
Show Images
Show Referer
Rotate13
Base64
Strip Meta
Strip Title
Session Cookies
Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42682646)
Watch
English
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.
scientific article published on 17 October 2017
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
meta-analysis
0 references
title
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
author
Hye Min Kim
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
Ja Seung Koo
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
author name string
Jinae Lee
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
language of work or name
English
0 references
publication date
17 October 2017
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
published in
BMC Cancer
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
volume
17
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
page(s)
690
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
cites work
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Prognostic significance of PD-L1 and PD-L2 in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Pembrolizumab for the treatment of non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Prognostic and predictive value of PDL1 expression in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
PD-1 blockade induces responses by inhibiting adaptive immune resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
PD-L1 expression in triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Role of PD-1 in HIV pathogenesis and as target for therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
What is heterogeneity and is it important?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Measuring inconsistency in meta-analyses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Operating characteristics of a rank correlation test for publication bias
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
27 May 2018
Anti-PD-L1 for metastatic triple-negative breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
16 August 2018
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
16 August 2018
Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
16 August 2018
Evidence for immune defects in breast and lung cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5645886
retrieved
16 August 2018
PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29041905
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/S12885-017-3670-1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
Dimensions Publication ID
1092249013
0 references
PMC publication ID
5645886
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
PubMed publication ID
29041905
1 reference
stated in
Europe PubMed Central
PMC publication ID
5645886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29041905%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit